Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
07/06/2011 | CN102114008A Clathrate of paeonol and preparation method and quality detection method thereof |
07/06/2011 | CN102114006A Preparation method of chitosan hollow and core-shell microcapsule with pH-sensitive burst release property |
07/06/2011 | CN102114005A Tracleer capsule and preparation method thereof |
07/06/2011 | CN102114003A Sustained-release pellet of hydroxysafflor yellow A as well as preparation method and applications thereof |
07/06/2011 | CN102114002A Enhanced immediate release formulations of topiramate |
07/06/2011 | CN102114000A Co-feeding lipid nano-delivery system for medicine carrying |
07/06/2011 | CN102113999A Novel multi-layer polysaccharide structure-modified liposome-encapsulated hemoglobin nano-capsule blood substitute |
07/06/2011 | CN102113997A Domperidone suspension and preparation method thereof |
07/06/2011 | CN102113996A Oral formulations containing protein or peptide, and preparation method and application thereof |
07/06/2011 | CN102113995A Constant-speed medicament release system and preparation method thereof |
07/06/2011 | CN102113994A Medicament for treating cerebral blood-vessel dilate and preparation method thereof |
07/06/2011 | CN101810620B Methionine-vitamin B1 composite injection and preparation method thereof |
07/06/2011 | CN101773469B Aztreonam/arginine medicament composition suspension injection |
07/06/2011 | CN101759170B Magnetic nano sheet-shaped hydroxyapatite and preparation method and application thereof |
07/06/2011 | CN101721390B Method for industrially preparing sodium alginate micro-capsule loading high-density cells |
07/06/2011 | CN101721371B Cefetamet pivoxil hydrochloride submicron emulsion solid preparation and new application thereof |
07/06/2011 | CN101703549B Atractylone lipidosome and preparation method thereof |
07/06/2011 | CN101693010B Cefathiamidine prosoma liposome preparation |
07/06/2011 | CN101669926B Liquid preparation for dosing nasal cavities and method for making the same |
07/06/2011 | CN101653610B Emulsifiable paste matrix of elemene transdermal preparation as well as preparation method and application thereof |
07/06/2011 | CN101653609B Octenyl succinate starch with colon targeting controlled release function and preparation method thereof |
07/06/2011 | CN101590055B Water soluble decoquinate and method for preparing same |
07/06/2011 | CN101579469B Medicament for curing chronic appendicitis and preparation method thereof |
07/06/2011 | CN101444514B Cefmenoxime hydrochloride preparation for injection and preparation method thereof |
07/06/2011 | CN101440136B Preparation of amine saccharification chitosan complex |
07/06/2011 | CN101406493B Microsphere for injection of Cordyceps sinensis and preparation method thereof |
07/06/2011 | CN101278953B Externally-applied medicine for curing hydrarthrosis of knee and method of processing the same |
07/06/2011 | CN101181263B Treatment of respiratory diseases |
07/06/2011 | CN101152186B Progesterone injection and method for preparing the same |
07/06/2011 | CN101141961B Stable particular pharmaceutical composition of solifenacin or salt thereof |
07/06/2011 | CN101111258B Emulsified composition for dilution and cancer vaccine composition |
07/05/2011 | USRE42524 Colloidal metal compositions and methods |
07/05/2011 | US7973150 Reducing the immunogenicity of fusion proteins |
07/05/2011 | US7973085 Gel composition |
07/05/2011 | US7973081 Emulsion compositions containing quaternary ammonium compounds |
07/05/2011 | US7972630 Injectable bone mineral substitute material |
07/05/2011 | US7972629 Product comprising a combination of milk serum apoproteins and free fatty acids |
07/05/2011 | US7972624 Method of manufacturing modified release dosage forms |
07/05/2011 | US7972623 Method for the production of effervescent granules in a vacuum |
07/05/2011 | US7972620 Polysaccharide capsules and methods of preparation |
07/05/2011 | US7972618 Edible water-soluble film containing a foam reducing flavoring agent |
07/05/2011 | US7972609 Method of treating cancer |
07/05/2011 | US7972608 Carrier proteins for vaccines |
07/05/2011 | US7972603 Stable immunogenic product comprising antigenic heterocomplexes |
07/05/2011 | US7972600 IGF-IR antagonists as adjuvants for treatment of prostate cancer |
07/05/2011 | CA2525553C Maytansinoid-antibody conjugate compositions |
07/05/2011 | CA2510175C 1-n-phenylamino-1h-imidazole derivatives and pharmaceutical compositions containing them |
07/05/2011 | CA2496469C Topical emulsion-gel composition comprising diclofenac sodium |
07/05/2011 | CA2488630C Immunoadhesin comprising a glycoprotein vi domain |
07/05/2011 | CA2475441C Sustained release preparations and process for producing the same |
07/05/2011 | CA2474386C Integrin targeted imaging agents |
07/05/2011 | CA2470668C 5ht4 partial agonist pharmaceutical compositions |
07/05/2011 | CA2439120C Erodible polymers for injection |
07/05/2011 | CA2439099C Anti-platelet and anti-thrombotic agents |
07/05/2011 | CA2416126C Bioabsorbable composites of derivatized hyaluronic acid |
07/05/2011 | CA2405767C Pharmaceutical formulations for dry powder inhalers |
07/05/2011 | CA2345027C Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
07/05/2011 | CA2288994C Polyalkylene oxide-modified single chain polypeptides |
07/05/2011 | CA2210656C Receptor specific transepithelial transport of immunogens |
06/30/2011 | WO2011079304A1 Methods and compositions related to annexin 1-binding compounds |
06/30/2011 | WO2011079279A2 Nanoconjugates and nanoconjugate formulations |
06/30/2011 | WO2011079260A2 Stabilized virus like particles having enhanced mucosal immunogenicity |
06/30/2011 | WO2011078457A2 Ph-sensitive block copolymer forming polyionic complex micelle, and drug or protein delivery vehicle using same |
06/30/2011 | WO2011078383A1 Low-viscosity liquid-crystal compound |
06/30/2011 | WO2011078367A1 Emulsion composition |
06/30/2011 | WO2011078204A1 Prophylactic or therapeutic agent for hyperlipemia, and anti-fatigue agent |
06/30/2011 | WO2011077843A1 Atrovastatin-containing coated preparation |
06/30/2011 | WO2011077587A1 Composition for inhibiting allergic diseases |
06/30/2011 | WO2011077458A1 Formulations of temozolomide for parenteral administration |
06/30/2011 | WO2011077405A1 Anionic polysaccharides functionalised by a hydrophobic acid derivative |
06/30/2011 | WO2011077402A2 Amphiphilic polymer functionalised by methionine |
06/30/2011 | WO2011077067A1 Polymer conjugates of non-glycosylated erythropoietin |
06/30/2011 | WO2011076970A1 Bioactive surface capable of genetically modifying biological cells or tissues and use thereof |
06/30/2011 | WO2011076807A2 Lipids, lipid compositions, and methods of using them |
06/30/2011 | WO2011076596A1 A combination for the treatment of osteoarthritis |
06/30/2011 | WO2011076401A1 Substantially water-free pharmaceutical compositions containing acetylsalicylic acid |
06/30/2011 | WO2011076391A1 Conjugate with target-finding ligand and use thereof |
06/30/2011 | WO2011076216A2 Wound care products |
06/30/2011 | WO2011075953A1 Multi-arm polyethylene glycol derivatives, conjugates and gels of drugs and the same |
06/30/2011 | WO2011075838A1 Method of treating or preventing hearing loss |
06/30/2011 | WO2011056115A8 Lipid layer forming composition for administration onto a surface of a living organism |
06/30/2011 | WO2011030351A3 Taste - masked pharmaceutical compositions |
06/30/2011 | WO2011022467A3 Controlled-release formulations of anabaseine compounds and uses thereof |
06/30/2011 | WO2011017101A3 Method for producing protein-carbohydrate vaccines reduced in free carbohydrate |
06/30/2011 | WO2011008992A3 Peptides whose uptake in cells is controllable |
06/30/2011 | WO2010146362A3 Materials and methods relating to glycosylation |
06/30/2011 | WO2010138194A3 Immunomodulatory agent-polymeric compounds |
06/30/2011 | WO2010117287A3 A virus-like particle vector for delivery of pharmaceutical agents, a process for the manufacture thereof, its uses and a pharmaceutical composition. |
06/30/2011 | US20110160708 Stable non-aqueous single phase viscous vehicles and formulations utlizing such vehicles |
06/30/2011 | US20110160311 Sweetness Enhancers, Compositions Thereof, and Methods for Use |
06/30/2011 | US20110160310 Tcb based hydrophilic polyurethane dispersions |
06/30/2011 | US20110160246 Neurodegenerative Protein Aggregation Inhibition Methods and Compounds |
06/30/2011 | US20110160224 Aripiprazole complex formulation and method |
06/30/2011 | US20110160173 Method Of Treating Human Skin And A Skin Care Composition For Use In Such A Method |
06/30/2011 | US20110160146 Conjungation of Small Molecules to Octaarginine Transporters for Overcoming Multi-Drug Resistance |
06/30/2011 | US20110160126 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
06/30/2011 | US20110159098 Stabilization and delivery of nucleic acid complexes |
06/30/2011 | US20110159083 Nanoparticles for protein drug delivery |
06/30/2011 | US20110159082 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
06/30/2011 | US20110159079 High Delivery Rates for Lipid Based Drug Formulations, and Methods of Treatment Thereof |